Solid Tumors: PYX-201 Treatment Study

We are testing a new drug, PYX-201, for patients with solid tumors. This study aims to understand its safety and how it may work in treating cancer.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Universitair Ziekenhuis Gent
Drug Research Unit
Ledeberg, Belgium
Institut Jules Bordet
Clinical Trial Conduct Unit
Negenmanneke, Belgium
Cliniques Universitaires Saint-Luc
Medical Oncology
Sint-Stevens-Woluwe, Belgium

Sponsor: Pyxis Oncology Inc.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.